Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Genome-wide association studies of coffee intake in UK/US participants of European ancestry uncover cohort-specific genetic associations
    Published on 2024-06-11
    2 years ago
  • Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking
    Published on 2024-06-11
    2 years ago
  • Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci
    Published on 2024-06-04
    2 years ago
  • Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam
    Published on 2024-05-31
    2 years ago
  • Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks
    Published on 2024-05-28
    2 years ago
  • Dorsal raphe to basolateral amygdala corticotropin-releasing factor circuit regulates cocaine-memory reconsolidation
    Published on 2024-05-27
    2 years ago
  • Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial
    Published on 2024-05-24
    2 years ago
« Previous 1 … 56 57 58 59 60 … 143 Next »
Journal of Psychopharmacology
  • Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
    Published on 2022-11-15
    3 years ago
  • Body mass index (BMI) does not predict responses to psilocybin
    Published on 2022-11-14
    3 years ago
  • Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice
    Published on 2022-11-02
    3 years ago
  • Association between quetiapine use and self-harm outcomes among people with recorded personality disorder in UK primary care: A self-controlled case series analysis
    Published on 2022-11-01
    3 years ago
  • Belief changes associated with psychedelic use
    Published on 2022-11-01
    3 years ago
  • Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes
    Published on 2022-10-31
    3 years ago
  • The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research
    Published on 2022-10-21
    3 years ago
« Previous 1 … 56 57 58 59 60 … 134 Next »
European Neuropsychopharmacology
  • A shared decision journey to bridge the gap between treatment recommendation and low adherence?
    Published on 2023-02-13
    3 years ago
  • Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence
    Published on 2023-02-13
    3 years ago
  • Treating major depressive disorder with mixed features
    Published on 2023-02-13
    3 years ago
  • New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging
    Published on 2023-02-13
    3 years ago
  • In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior
    Published on 2023-02-12
    3 years ago
  • Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
    Published on 2023-02-08
    3 years ago
  • Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study
    Published on 2023-02-03
    3 years ago
« Previous 1 … 56 57 58 59 60 … 154 Next »

   Pharma Pub